期刊
PHARMACOLOGY RESEARCH & PERSPECTIVES
卷 9, 期 2, 页码 -出版社
JOHN WILEY & SONS LTD
DOI: 10.1002/prp2.721
关键词
C. elegans; drug discovery; genetic screenings; human disease models; pharmacological screenings
资金
- Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 2015-2017 CO 11220150100182CO]
- Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2017 0566]
- Universidad Nacional del Sur [PGI 2016 24/B261, PGI 2018 24/B291]
This review highlights the reasons why Caenorhabditis elegans is positioned as an outstanding cost-effective option for drug discovery, as well as the advantages and drawbacks of this model. The suitability of C. elegans in large-scale genetic and pharmacological screenings is emphasized, and its high-throughput screenings have contributed to the breakthrough of various candidate compounds involved in extensive fields.
Therapeutic drug development is a long, expensive, and complex process that usually takes 12-15 years. In the early phases of drug discovery, in particular, there is a growing need for animal models that ensure the reduction in both cost and time. Caenorhabditis elegans has been traditionally used to address fundamental aspects of key biological processes, such as apoptosis, aging, and gene expression regulation. During the last decade, with the advent of large-scale platforms for screenings, this invertebrate has also emerged as an essential tool in the pharmaceutical research industry to identify novel drugs and drug targets. In this review, we discuss the reasons why C. elegans has been positioned as an outstanding cost-effective option for drug discovery, highlighting both the advantages and drawbacks of this model. Particular attention is paid to the suitability of this nematode in large-scale genetic and pharmacological screenings. High-throughput screenings in C. elegans have indeed contributed to the breakthrough of a wide variety of candidate compounds involved in extensive fields including neurodegeneration, pathogen infections and metabolic disorders. The versatility of this nematode, which enables its instrumentation as a model of human diseases, is another attribute also herein underscored. As illustrative examples, we discuss the utility of C. elegans models of both human neurodegenerative diseases and parasitic nematodes in the drug discovery industry. Summing up, this review aims to demonstrate the impact of C. elegans models on the drug discovery pipeline.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据